[2] Patients should contact their GP if they experience: Side effects from B12 injections (though these are rare and usually mild) Difficulty attending scheduled injection appointments, as missed doses may lead to symptom recurrence New symptoms developing during treatment Concerns about treatment effectiveness or duration Changes in other medications that might affect B12 absorption Suspected adverse reactions to B12 treatment can be reported through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Analytical Method & Instrumentation Standard:ICP-MS per ICH Q3D(R2) / USP Instrument:Agilent 7900 ICP-MS (SN: JP71586) with He collision mode Sample Preparation:Closed-vessel microwave digestion (CEM MARS 6): 52.1 mg + 5 mL HNO (suprapure) + 1 mL HO (30%) Digestion Program:Ramp 20 min 200C, hold 15 min, cool to RT, dilute to 50.0 mL (Milli-Q) Calibration:Multi-element std (NIST SRM 3100 series), 5-point external cal
Because these medications significantly slow down gastric emptying (the speed at which food leaves your stomach), the environment of your gut changes
Furthermore, AI and machine learning methodologies can be incorporated for real-world data analysis such as for surveying social media trends for better understanding of patient experiences and misconceptions about GLP-1 RAs, in identification of potential treatment barriers like insurance coverage limitations and concerns regarding side effects for developing targeted interventions and also in evaluation of treatment efficacy in real-world settings